BridgeMD
New treatment option for PTSD
Official title Sensory Motor Arousal Regulation Treatment (SMART) Study
ClinicalTrials.gov ID: NCT06035809
What this study is testing
- What it's testing
- This study will investigate whether a movement and body-based treatment can benefit adults with Post-traumatic Stress Disorder (PTSD). The treatment is called Sensory Motor Arousal Regulation Treatment, or "SMART", and study participation involves 8 sessions of SMART, as well as pre-treatment, post-treatment, and 3-month follow-up assessments.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adults, aged 18-65
- A primary diagnosis of PTSD as determined by our pre-treatment assessment
- Ability to provide informed consent
- Fluency in written and spoken English (to be able to complete assessments)
- Lives within 30km of London, ON
You likely can't join if
- any implants, conditions, etc. that do not comply with 7T (Tesla) fMRI research safety standards (e.g., pacemaker, pregnancy/possible pregnancy)
- history of significant head injury/lengthy loss of consciousness (e.g., a Glasgow Coma Scale Score \< 15 at the time of incident as assessed...
- significant untreated medical illness
- history of neurological or neurodevelopmental disorder
- history of any pervasive developmental disorder
- lifetime bipolar or psychotic disorder
See the full eligibility criteria
- Adults, aged 18-65
- A primary diagnosis of PTSD as determined by our pre-treatment assessment
- Ability to provide informed consent
- Fluency in written and spoken English (to be able to complete assessments)
- Lives within 30km of London, ON
- any implants, conditions, etc. that do not comply with 7T (Tesla) fMRI research safety standards (e.g., pacemaker, pregnancy/possible pregnancy)
- history of significant head injury/lengthy loss of consciousness (e.g., a Glasgow Coma Scale Score \< 15 at the time of incident as assessed retrospectively by participant)
- significant untreated medical illness
- history of neurological or neurodevelopmental disorder
- history of any pervasive developmental disorder
- lifetime bipolar or psychotic disorder
- alcohol/substance abuse or dependence within the last 3 months
- extensive narcotic use (e.g., fentanyl, oxycodone, etc.)
- anyone who would not be suitable for short-term treatment (as determined by our pre-treatment assessment)
- suicide attempt in last 6 months
The study team makes the final eligibility decision.
Where it's taking place
- London, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.